The abstract is read at the publisher; the summary is JClub's.
Eighteen prospective cohort studies collected faecal samples from at least 5000 individuals each, enabling projected colorectal, stomach, pancreatic, and female breast cancer case counts for future microbiome-risk analyses.
- Why it matters: Cross-sectional comparisons link the gut microbiome to cancer but cannot establish causation, so prospective sampling before diagnosis is needed to assess cancer risk.
- What they did: The work identified 18 prospective cohorts with faecal collection prior to cancer diagnosis and estimated projected incident cases for colorectal, stomach, pancreatic, and female breast cancers.
- The result: More incident cases are needed to find robust microbiome–cancer associations with adequate power, motivating additional cohorts, data sharing, and pooled meta-analysis to study microbiome roles across body sites.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.